With extensive experience in the pharmaceutical and biotechnology sectors, Rob Chioini has played a key role in developing innovative therapies for patients with end-stage renal disease, helping drive meaningful improvements in treatment outcomes and quality of care.
Address
Contact Rob Chioini:
